Global Glioblastoma Multiforme Treatment Market to Grow at 7.9% During 2022-2027, Catalyzed by Increasing Geriatric Population

November 04, 2019

According to the latest report by IMARC Group, titled “Glioblastoma Multiforme Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global glioblastoma multiforme treatment market reached a value of US$ 1.8 Billion in 2021. Glioblastoma multiforme (GBM) is a grade IV glioma brain tumor, which is often considered the most lethal form of brain cancer. It arises from star-shaped glial cells that support the health of the nerve cells in the brain. This form of cancer is characterized by rapid growth and invasion, aided by cell migration and degradation of the extracellular matrix. Since GBM is largely treatment-resistant in nature and the treatment methods are unlikely to result in an extended remission of the GBM tumors, the overall mortality rates of patients remain high with short post-diagnosis survival period. However, the contemporary treatment methods, such as surgery, radiation and chemotherapy, are largely palliative, which aids in prolonging the lives of the patients while improving the quality of their lives.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Global Glioblastoma Multiforme Treatment Market Trends:

The market is primarily driven by a significant increase in the geriatric population, who are the most prone to chronic ailments. Moreover, sedentary lifestyle habits and increasing alcohol consumption, especially among the majority of the urban population, have contributed to the increasing prevalence of various types of cancers. Continuous advancements made in the fields of molecular biology and gene technology to develop efficient treatment options have led to a better understanding of the gene mutations and molecular mechanisms, in confluence with clinical trials. These promising and tailored therapeutic approaches are anticipated to provide a further thrust to the market growth. On account of the aforementioned factors, the market is expected to grow at a CAGR of 7.9% during 2022-2027.

Market Summary:

  • On the basis of the drug type, the market has been divided into temozolomide, bevacizumab, carmustine, radiosensitizers and others.
  • Based on the route of administration, the market has been bifurcated into oral and parenteral.
  • On the basis of the type of molecule, the market has been segregated into small molecules and biologics.
  • Based on the distribution channel, the market has been categorized into hospitals, pharmacies and others.
  • On the geographical front, the market has been classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
  • The competitive landscape of the market has also been studied with the detailed profiles of the key players. Some of these players include Sun Pharmaceutical Industries Limited, Celldex Therapeutics, Inc., Pfizer Inc., F. Hoffmann-La Roche AG, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd., Exelixis, Inc., Angiochem Inc., and Arbor Pharmaceuticals Inc.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

Tel no: +1-631-791-1145
Follow us on twitter: @imarcglobal

Global Glioblastoma Multiforme Treatment Market to Grow at 7.9% During 2022-2027, Catalyzed by Increasing Geriatric Population
Select Licence Type

Benefits of Customization

Personalize This Research

Triangulate with your Data

Get Data as per your Format and Definition

Gain a Deeper Dive into a Specific Application, Geography, Customer or Competitor

Any level of Personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Bayer AH

It was indeed a great experience to work with IMARC on the assignment on Aqua market. The team had done a fantastic job in terms of what was expected, what was assured and what was the result… the report gave us many insights and market know how which allowed us to work on our strength and define exact strategies…

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More